Ocular Therapeutix, Inc.
OCUL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $392 | $196 | $102 | $164 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $32 | $26 | $21 | $21 |
| Inventory | $3 | $2 | $2 | $1 |
| Other Curr. Assets | $13 | $8 | $4 | $5 |
| Total Curr. Assets | $441 | $232 | $130 | $191 |
| Property Plant & Equip (Net) | $15 | $18 | $18 | $12 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $2 |
| Total NC Assets | $17 | $20 | $20 | $14 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $458 | $252 | $149 | $205 |
| Liabilities | – | – | – | – |
| Payables | $4 | $4 | $5 | $5 |
| Short-Term Debt | $2 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $1 | $0 |
| Other Curr. Liab. | $35 | $29 | $24 | $20 |
| Total Curr. Liab. | $41 | $35 | $31 | $26 |
| LT Debt | $74 | $82 | $63 | $57 |
| Deferred Rev, NC | $14 | $14 | $13 | $13 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $13 | $30 | $6 | $20 |
| Total NC Liab. | $101 | $126 | $83 | $91 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $8 | $10 | $8 |
| Total Liabilities | $143 | $161 | $114 | $117 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$891 | -$698 | -$617 | -$546 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $1,206 | $789 | $652 | $634 |
| Total Equity | $315 | $91 | $35 | $88 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $458 | $252 | $149 | $205 |
| Net Debt | -$316 | -$112 | -$38 | -$105 |